259 related articles for article (PubMed ID: 9781363)
21. Lactoferrin peptide increases the survival of Candida albicans-inoculated mice by upregulating neutrophil and macrophage functions, especially in combination with amphotericin B and granulocyte-macrophage colony-stimulating factor.
Tanida T; Rao F; Hamada T; Ueta E; Osaki T
Infect Immun; 2001 Jun; 69(6):3883-90. PubMed ID: 11349055
[TBL] [Abstract][Full Text] [Related]
22. Effects of imidazole- and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae.
Odds FC; Cockayne A; Hayward J; Abbott AB
J Gen Microbiol; 1985 Oct; 131(10):2581-9. PubMed ID: 2999296
[TBL] [Abstract][Full Text] [Related]
23. Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates.
Kuipers ME; de Vries HG; Eikelboom MC; Meijer DK; Swart PJ
Antimicrob Agents Chemother; 1999 Nov; 43(11):2635-41. PubMed ID: 10543740
[TBL] [Abstract][Full Text] [Related]
24. Effects of lactoferrin and lactoferricin on the release of interleukin 8 from human polymorphonuclear leukocytes.
Shinoda I; Takase M; Fukuwatari Y; Shimamura S; Köller M; König W
Biosci Biotechnol Biochem; 1996 Mar; 60(3):521-3. PubMed ID: 8901116
[TBL] [Abstract][Full Text] [Related]
25. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory effects of bovine lactoferrin and lactoferricin B on Enterobacter sakazakii.
Wakabayashi H; Yamauchi K; Takase M
Biocontrol Sci; 2008 Mar; 13(1):29-32. PubMed ID: 18432114
[TBL] [Abstract][Full Text] [Related]
27. Anti-candidal activity of essential oils alone and in combination with amphotericin B or fluconazole against multi-drug resistant isolates of Candida albicans.
Khan MS; Malik A; Ahmad I
Med Mycol; 2012 Jan; 50(1):33-42. PubMed ID: 21756200
[TBL] [Abstract][Full Text] [Related]
28. Impact of lysozyme and lactoferrin on oral Candida isolates exposed to polyene antimycotics and fluconazole.
Anil S; Samaranayake LP
Oral Dis; 2002 Jul; 8(4):199-206. PubMed ID: 12206401
[TBL] [Abstract][Full Text] [Related]
29. [Synergistic effect of azole antimycotics (clotrimazole and fluconazole) and natural substances].
Kuruc M; Čonková E
Ceska Slov Farm; 2017; 66(4):164-167. PubMed ID: 29351379
[TBL] [Abstract][Full Text] [Related]
30. In vitro and in vivo antifungal activities of FX0685, a novel triazole antifungal agent with potent activity against fluconazole-resistant Candida albicans.
Takahata S; Okutomi T; Ohtsuka K; Hoshiko S; Uchida K; Yamaguchi H
Med Mycol; 2005 May; 43(3):227-33. PubMed ID: 16010849
[TBL] [Abstract][Full Text] [Related]
31. Sensitivity of Candida albicans to essential oils: are they an alternative to antifungal agents?
Bona E; Cantamessa S; Pavan M; Novello G; Massa N; Rocchetti A; Berta G; Gamalero E
J Appl Microbiol; 2016 Dec; 121(6):1530-1545. PubMed ID: 27568869
[TBL] [Abstract][Full Text] [Related]
32. Effect of orally administered bovine lactoferrin on the immune response in the oral candidiasis murine model.
Takakura N; Wakabayashi H; Ishibashi H; Yamauchi K; Teraguchi S; Tamura Y; Yamaguchi H; Abe S
J Med Microbiol; 2004 Jun; 53(Pt 6):495-500. PubMed ID: 15150327
[TBL] [Abstract][Full Text] [Related]
33. Human recombinant lactoferrin acts synergistically with antimicrobials commonly used in neonatal practice against coagulase-negative staphylococci and Candida albicans causing neonatal sepsis.
Venkatesh MP; Rong L
J Med Microbiol; 2008 Sep; 57(Pt 9):1113-1121. PubMed ID: 18719181
[TBL] [Abstract][Full Text] [Related]
34. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT
J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462
[TBL] [Abstract][Full Text] [Related]
35. Reversal of Azole Resistance in Candida albicans by Sulfa Antibacterial Drugs.
Eldesouky HE; Mayhoub A; Hazbun TR; Seleem MN
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263071
[TBL] [Abstract][Full Text] [Related]
36. Synthetic porcine lactoferricin with a 20-residue peptide exhibits antimicrobial activity against Escherichia coli, Staphylococcus aureus, and Candida albicans.
Chen HL; Yen CC; Lu CY; Yu CH; Chen CM
J Agric Food Chem; 2006 May; 54(9):3277-82. PubMed ID: 16637685
[TBL] [Abstract][Full Text] [Related]
37. Fungicidal effect of human lactoferrin against Candida albicans.
Soukka T; Tenovuo J; Lenander-Lumikari M
FEMS Microbiol Lett; 1992 Jan; 69(3):223-8. PubMed ID: 1555756
[TBL] [Abstract][Full Text] [Related]
38. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
Martín E; Parras P; Lozano MC
Chemotherapy; 1992; 38(5):335-9. PubMed ID: 1337508
[TBL] [Abstract][Full Text] [Related]
39. Anti-Candida activity of calprotectin in combination with neutrophils or lactoferrin.
Okutomi T; Tanaka T; Yui S; Mikami M; Yamazaki M; Abe S; Yamaguchi H
Microbiol Immunol; 1998; 42(11):789-93. PubMed ID: 9886152
[TBL] [Abstract][Full Text] [Related]
40. Correlation between in vitro and in vivo activity of antifungal agents against Candida species.
Anaissie EJ; Karyotakis NC; Hachem R; Dignani MC; Rex JH; Paetznick V
J Infect Dis; 1994 Aug; 170(2):384-9. PubMed ID: 8035024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
